Skip to main content
. 2014 Oct 22;19(6):893–899. doi: 10.1007/s00776-014-0642-z

Table 1.

Demographic and clinical characteristics of the patients

Pregabalin group (n = 49) Control group (n = 47) P value
Age (years) 68.1 ± 1.56 68.5 ± 1.48 0.983a
Sex 0.484a
Male 27 (55.1) 22 (46.8)
Female 22 (44.9) 25 (53.2)
American Society of Anesthesiologists physical status 0.997a
Level I 25 (51.0) 24 (51.1)
Level II 24 (49.0) 23 (48.9)
Current smoker 4 (8.1) 3 (6.4) 0.881a
Manual laborer 13 (26.5) 12 (25.5) 0.933a
Professional qualification (s) 10 (20.4) 9 (19.1) 0.915a
Duration of pain, months 23.0 ± 6.19 26.4 ± 8.48 0.745a
Affected spinal level 0.889a
L3–L4 5 (10.2) 5 (10.6)
L4–L5 42 (85.7) 39 (83.0)
L5–S1 2 (4.1) 3 (6.4)
Number of spinal stenosis levels on magnetic resonance images 0.679a
One level 30 (61.2) 31 (66.0)
Two levels 14 (28.6) 12 (25.5)
More than three levels 5 (10.2) 4 (8.5)
Cause of lumbar spinal stenosis 0.129a
Lumbar spondylitis 38 (77.6) 29 (61.7)
Degenerative spondylolisthesis 11 (22.4) 18 (38.3)

Data are shown as mean ± standard error or n (%)

aMann-Whitney U test